Little Retail Impact Seen From Pfizer Buy

Pfizer's acquisition of Wyeth may shake up the pharmaceutical industry, but executives contacted by SN said it would have little impact on supermarket pharmacy. The definitive merger was reported last week. Pfizer, here, will buy Wyeth, Madison, N.J., in a cash-and-stock transaction valued at $50.19 per share, or a total of about $68 billion. Some 8,000 jobs are expected to be eliminated.

NEW YORK — Pfizer's acquisition of Wyeth may shake up the pharmaceutical industry, but executives contacted by SN said it would have little impact on supermarket pharmacy.

The definitive merger was reported last week. Pfizer, here, will buy Wyeth, Madison, N.J., in a cash-and-stock transaction valued at $50.19 per share, or a total of about $68 billion. Some 8,000 jobs are expected to be eliminated.

Pfizer is the nation's leading pharmaceutical manufacturer, but

Register to view the full article

test - Advanced Registered User

Already a member? .